Search results
Results from the WOW.Com Content Network
Estrogen is the predominant sex hormone that slows bone loss (even in men). Both estrogen and testosterone help stimulate bone formation (T, especially at puberty). Testosterone may cause an increase in cortical bone thickness in transgender men (however this does not necessarily translate to a greater mechanical stability).
Gynecomastia can respond well to medical treatment although it is usually only effective when done within the first two years after the start of male breast enlargement. [7] Selective estrogen receptor modulators (SERMs) such as tamoxifen , raloxifene , and clomifene may be beneficial in the treatment of gynecomastia but are not approved by the ...
Signs of hyperestrogenism may include heightened levels of one or more of the estrogen sex hormones (usually estradiol and/or estrone), lowered levels of follicle-stimulating hormone and/or luteinizing hormone (due to suppression of the hypothalamic–pituitary–gonadal axis by estrogen), and lowered levels of androgens such as testosterone (generally only relevant to males). [1]
Treatment will completely depend on the cause of the bleeding but can be as simple as a change or addition in birth control pills or an antibiotic medication to clear up a bacterial infection ...
Estrogen receptor-positive breast cancer in women [1] As a means of androgen deprivation therapy for prostate cancer and benign prostatic hyperplasia in men [7] [8] [10] In combination with progestins for endometriosis in women. Although initially used alone, progestins were added in the 1960s and 1970s. [11]
It didn’t seem to matter that the Menopause Society issued a position statement in 2017—which it reaffirmed in 2022—saying that hormone therapy was the “most effective treatment” for hot ...
An estrogen (E) is a type of medication which is used most commonly in hormonal birth control and menopausal hormone therapy, and as part of feminizing hormone therapy for transgender women. [1] They can also be used in the treatment of hormone-sensitive cancers like breast cancer and prostate cancer and for various other
Estradiol undecylate has been used as a form of high-dose estrogen therapy to treat prostate cancer, but has since largely been superseded for this indication by newer agents with fewer adverse effects (e.g., gynecomastia and cardiovascular complications) like GnRH analogues and nonsteroidal antiandrogens.